Flavonoids in food and natural antioxidants in wine

Current Opinion in Lipidology

Volumn 10, Issue 1, 1999, Pages 23-28

  Lairon, Denis ^a   Amiot, Marie J ^b  

^a INSERM   (France)

^b CEMAGREF   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; FLAVONOID; LOW DENSITY LIPOPROTEIN;

FOOD; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; REVIEW; WINE;

ANTIOXIDANTS; BIOLOGICAL AVAILABILITY; CORONARY DISEASE; FLAVONOIDS; HUMANS; TEA; WINE;

ANIMALIA;

EID: 0032965758     PISSN: 09579672     EISSN: None     Source Type: Journal    
DOI: 10.1097/00041433-199902000-00005     Document Type: Review

References (41)

1. Ho CT. Antioxidant properties of plant flavonoids. In: Food factors for cancer prevention. Ohigashi H, Osawa T, Terao J, Watanabe S, Yoshikawa T (editors). Tokyo: Springer-Verlag; 1997. pp. 593-597.
2. Hertog MGL. Flavonols in wine and tea and prevention of coronary heart disease. In: Polyphenols 96. Vercauteren J, Chèze C, Triaud J (editors). Paris: INRA; 1998. pp. 117-131. This review describes epidemiologic (observational and experimental) studies on tea, wine and flavonols.
3. Frankel EN. Nutritional benefits of flavonoids. In: Food factors for cancer prevention. Ohigashi H, Osawa T, Terao J, Watanabe S, Yoshikawa T (editors). Tokyo: Springer-Verlag; 1997. pp 613-616.
4. Suschetet M, Siess MH, Le Bon AM, Canivenc-Lavier MC. Anticarcinogenic properties of some flavonoids. In: Polyphenols 96. Vercauteren J, Chèze C, Triaud J (editors). Paris: INRA; 1998. pp. 165-204.
5. Haslam E. Practical polyphenolics. From structure to molecular recognition and physiological action. Cambridge: Cambridge University Press; 1998. This book describes the scientific basis for the action of plant polyphenols in a wide range of technologically important phenomena. The role of polyphenols is discussed in different areas: agriculture, food science, oenology, natural medicines (the so-called 'French Paradox').
6. Böhm H, Boeing H, Hempel J, Raab B, Kroke A. Flavonole, flavone und anthocyane als natärliche antioxidantien der nöhrung und ihre mögliche rolle bei der prāvention chronischer erkrankungen. Z Ernährungswiss 1998; 37:147-163.
7. Soleas GJ, Diamandis EP, Goldberg DM. Wine as a biological fluid: history, production, and role in disease prevention. J Clin Lab Anal 1997; 11:287-313.
8. Justesen U, Knuthsen P, Leth T. Quantitative analysis of flavonols, flavones, and flavanones in fruits, vegetables and beverages by high-performance liquid chromatography with photo-diode array and mass spectrometric detection. J Chromatogr A 1998; 799:101-110.
9. Mouly P, Gaydou EM, Auffray A. Simultaneous separation of flavanone glycosides and polymethoxylated flavones in citrus juices using liquid chromatography. J Chromatogr A 1998; 800:171-179.
10. Brouillard R, George F, Fougerousse A. Polyphenols produced during red wine ageing. Biofactors 1997; 6:403-410.
11. Rice-Evans CA, Miller NJ, Papanga G. Antioxidant properties of phenolic compounds. Trends Plant Sci 1997; 2:152-159.
12. de Groot H, Rauen U. Tissue injury by reactive oxygen species and the protective effects of flavonoids. Fundam Clin Pharmacol 1998; 12:249-255.
13. 2+ ions: implications for their antioxidant properties. Biochem J 1998; 330:1173-1178.
14. Bors W, Michel C, Stettmaier K. Antioxidant effects of flavonoids. Biofactors 1997; 6:399-402.
15. Arora A, Nair MG, Strasburg GM. Structure-activity relationships for antioxidant activities of a series of flavonoids in a liposomal system. Free Radical Biol Med 1998; 24:1355-1363.
16. Garewal HS. Antioxidants and disease prevention. Boca Raton: CRC Press; 1997.
17. Hollman PC, Tijburg LB, Yang CS. Bioavailability of flavonoids from various tea. CRC Rev Food Sci Nutr 1997; 37:719-738.
18. Otero P, Viana M, Herrera E, Bonet B. Antioxidant and prooxidant effects of ascorbic acid, dehydroascorbic acid and flavonoids on LDL submitted to different degrees of oxidation. Free Radic Res 1997; 27:619-626.
19. Miyagi Y, Miwa K, Inoue H. Inhibition of human low-density lipoprotein oxidation by flavonoids in red wine and grape juice. Am J Cardiol 1997; 80:1627-1631. The antioxidant properties of red wine and grape juice rich in flavonoids, compared to white wine and beer, were studied in vitro and after 1 and 2 h beverage consumption by volunteers. The antioxidant capacity of red wine and grape juice were comparable in vitro but the inhibition of LDL oxidation after beverage ingestion was important with red wine only. Different proportions of monomeric/ polymeric forms of flavonoids in red wine and grape juice could explain the differences observed.
20. Kerry NL, Abbey M. Red wine and fractionated phenolic compounds prepared from red wine inhibit low density lipoprotein oxidation in vitro. Atherosclerosis 1997; 135:93-102. Using a conventional in-vitro approach, these authors show that red wine but not ethanol or red wine depleted in phenolic compounds markedly delay and lower LDL oxidation and reduce uptake of this LDL by cultured macrophages. Red wine fractions rich in catechins and monomeric anthocyanidins displayed the most important effects.
21. Vinson JA, Dabbagh YA. Tea phenols: antioxidant effectiveness of teas, tea components, tea fractions and their binding with lipoproteins. Nutr Res 1998; 18:1067-1075.
22. van het Hof KH, de Boer HS, Wiesman SA, Lien N, Wesstrate JA, Tijburg LB. Consumption of green and black tea does not increase resistance of low- density lipoprotein to oxidation in humans. Am J Clin Nutr 1997; 66:1125-1132.
23. Princen HM, van Duyvenvoorde W, Buytenhek R, Blonk C, Tijburg LB, Langius JA, et al. No effect of consumption of green and black tea on plasma lipid and antioxidant levels and on LDL oxidation in smokers. Arterioscler Thromb Vasc Biol 1998; 18:833-841.
24. McAnlis GT, McEnemy J, Pearce J, Young IS. Black tea consumption does not protect low density lipoprotein from oxidative modification. Eur J Clin Nutr 1998; 52:202-206.
25. Janssen K, Mensink RP, Cox FJ, Harryvan JL, Hovenier R, Hollman PC, et al. Effects of the flavonoids quercetin and apigenin on hemostasis in healthy volunteers: results from an in vitro and a dietary supplement study. Am J Clin Nutr 1998; 67:255-262.
26. Ishikawa T, Suzukawa M, Ito T, Yoshida H, Ayaori M, Nishiwaki M, et al. Effect of tea flavonoid supplementation on the susceptibility of low-density lipoprotein to oxidative modification. Am J Clin Nutr 1997; 66:261-266.
27. Nigdikar SV, Williams NR, Griffin BA, Howard AN. Consumption of red wine polyphenols reduces the susceptibility of low-density lipoproteins to oxidation in vivo. Am J Clin Nutr 1998; 68:258-265. This paper reports on an intervention study during which healthy men ingested phenolic supplements for 2 weeks, in the form of red or white wine (375 ml/day) or extracted polyphenols from red or white wine (1 g/day). The lag-time for copper- induced oxidation of LDL was increased and plasma lipid peroxides decreased after consumption of the supplements. It is pointed out that the use of different techniques could give rise to conflicting data in different studies.
28. Serafini M, Maiani G, Ferro-Luzzi A. Alcohol-free red wine enhances plasma antioxidant capacity in humans. J Nutr 1998; 128:1003-1007.
29. Day AP, Kemp HJ, Bolton C, Hartog M, Stansbie D. Effect of concentrated red grape juice consumption on serum antioxidant capacity and low-density lipoprotein oxidation. Ann Nutr Metab 1997; 41:353-357.
30. Gorinstein S, Zemser M, Berliner M, Goldstein R, Libman I, Trakhtenberg S, Caspi A. Moderate consumption and positive biochemical changes in patients with coronary atherosclerosis. J Intern Med 1997; 242:219-224.
31. Carbonneau MA, Leger CL, Monnier L, Bonnet C, Michel F, Fouret G, et al. Supplementation with wine phenolic compounds increases the antioxidant capacity of plasma and vitamin E of low-density lipoprotein without changing the lipoprotein Cu(2+)-oxidizability: possible explanation by phenolic location. Eur J Clin Nutr 1997; 51:682-690. A group of healthy volunteers was tested before and after supplementation with a red wine phenolic extract. The antioxidant capacity of the plasma was enhanced after supplementation and the respective action of compounds at the lipid interface or aqueous phase was investigated.
32. Belguendouz L, Fremont L, Gozzelino MT. Interaction of transresveratrol with plasma lipoproteins. 1998; 55:811-816.
33. Hayek T, Fuhrman B, Vaya J, Rosenblat M, Belinky P, Colemen R, et al. Reduced progression of atherosclerosis in apolipoprotein E-deficient mice following consumption of red wine, or its polyphenols quercetin or catechin, is associated with reduced susceptibility of LDL to oxidation and aggregation. Arterioscler Thromb Vasc Biol 1997; 17:2744-2752. In an animal model of atherosclerosis, chronic ingestion of catechin, quercetin or red wine significantly reduced the atherosclerotic lesion area with associated reduction in LDL oxidability.
34. Hollman PC, van Trijp JM, Buysman MN, van der Gaag MS, Mengelers MJ, de Vries JH, et al. Relative bioavailability of the antioxidant quercetin from various foods in man. FEBS Lett 1997; 418:152-156. Nine individuals ingested flavonols as different conjugated forms provided from onions (quercetin-monoglucosides), apples (quercetin-galactoside, -arabinoside, -rhamnoside, -xyloside and -glucoside) and as pure rutin (quercetin-rutinoside), the major quercetin glycoside found in tea. Conjugation with glucose enhanced the absorption of quercetin from the small gut.
35. Manach C, Morand C, Crespy V, Demigne C, Texier O, Regerat F, et al. Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties. FEBS Lett 1998; 426:331-336. Following a mixed meal rich in flavonols, quercetin levels were measured in the plasma of healthy volunteers. A maximal concentration was found in plasma after 3 h with a further decline to baseline levels attained after 20 h. Circulating conjugated forms of quercetin prolonged lag time of LDL oxidation but with a twofold lower magnitude than aglycone form.
36. Hollman PC, Katan MB. Bioavailability and health effects of dietary flavonols in man. Arch Toxicol Suppl 1998; 20:237-248.
37. Walgren RA, Walle UK, Walle T. Transport of quercetin and its glucosides across human intestinal epithelial Caco-2 cells. Biochem Pharmacol 1998; 55:1721-1727.
38. Remesy C, Manach C, Demigne C, Texier O, Regerat F. Interest of polphenols in preventive nutrition. In Polyphenols 96, Vercauteren J, Chèze C, Triaud J (editors). Paris: INRA; 1998. pp. 251-265.
39. Boulton DW, Walle UK, Walle T. Extensive binding of the bioflavonoid quercetin to human plasma proteins. J Pharm Pharmacol 1998; 50:243-249.
40. Morand C, Crespy V, Manach C, Besson C, Demigne C, Remesy C. Plasma metabolites of quercetin and their antioxidant properties. Am J Physiol 1998; 275:R212-R219.
41. de Vries JH, Hollman PC, Meyboom S, Buysman MN, Zock PL, van Staveren WA, et al. Plasma concentrations and urinary excretion of the antioxidant flavonols quercetin and kaempferol as biomarkers for dietary intake. Am J Clin Nutr 1998; 68:60-65.